SNUG01 is a first-in-class targeted gene therapy that’s designed to increase the levels of TRIM72, a protein with ...

Given the variations for each person with ALS, what works for one might not be ideal for another, writes columnist.

Californians can contribute to ALS research by making donations when filing their state income taxes, the ALS Network said.

Neurosense reports Canadian regulators want a meeting that could lead to PrimeC's conditional approval there, and further ...

Scientists have developed a new method that can grow motor neurons from skin cells, which may serve as a platform for ALS ...

NUZ-001 slowed respiratory declines in ALS patients in a Phase 1 trial, and Neurizon is working to ready it for the HEALEY ...

Certain subsets of immune NK cells were altered in the blood of people with ALS, and could serve as therapeutic targets, a ...

After her late husband's ALS diagnosis, columnist Juliet Taylor connected with other caregivers who provided support and ...

With ALS, columnist Dagmar Munn often has trouble using plastic bottles, but she's found a few strategies for navigating ...

Guest writer Anita Newton highlights the importance of finding purpose after experiencing loss. Anita's purpose is writing ...

A cholesterol receptor protein called LDLR appears to be a key driver of neurotoxicity in sporadic ALS, per new research ...

Preclinical data with the investigational gene therapy INS1202 show improvements in survival and motor performance in ALS.